A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study

To develop a model of offering population carrier screening for fragile X syndrome to nonpregnant women in primary care, using a program evaluation framework. A three-phase approach included: (I) needs assessment exploring staff and client attitudes, and informing development of educational material...

Full description

Saved in:
Bibliographic Details
Published inGenetics in medicine Vol. 10; no. 7; pp. 525 - 535
Main Authors Metcalfe, Sylvia, Jacques, Alice, Archibald, Alison, Burgess, Trent, Collins, Veronica, Henry, Anna, McNamee, Kathleen, Sheffield, Leslie, Slater, Howard, Wake, Samantha, Cohen, Jonathan
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.07.2008
Nature Publishing Group US
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To develop a model of offering population carrier screening for fragile X syndrome to nonpregnant women in primary care, using a program evaluation framework. A three-phase approach included: (I) needs assessment exploring staff and client attitudes, and informing development of educational materials, questionnaires and protocols; (II) offering screening to women, with questionnaires at baseline (Q1) and another (Q2) 1-month later; (III) genetic counseling for test-positive women and interviews with a subgroup of participants. Of 338 volunteering for Phase II, 94% completed Q1, 59% completed Q2, and 20% (N = 65) chose testing revealing one premutation carrier and three gray zone results; 31 women were interviewed. Tested women had more positive attitudes toward screening (Q1: P < 0.001; Q2: P < 0.001) compared with untested, although there was no significant difference in mean knowledge scores or anxiety. Women generally supported being offered prepregnancy screening; however, reasons against being tested included: not currently planning a family; perceiving benefits of screening as unimportant; and having to return for testing. This is the first prospective study exploring informed decision-making for fragile X syndrome carrier screening, using a thorough process of consultation, with no apparent harms identified. It provides a model for development of future genetic screening programs.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1098-3600
1530-0366
DOI:10.1097/GIM.0b013e31817c036e